AstraZeneca's biotech arm, MedImmune, is doing its part in a corporate restructuring operation--axing 200 workers and relocating 100 others as it shutters a pair of facilities in California.
MedImmune's infectious disease and vaccine research centers in Mountain View and Santa Clara, CA, are being closed in the restructuring.
Read more: AZ's MedImmune axing 200 in California R&D restructuring - FierceBiotech http://www.fiercebiotech.com/story/azs-medimmune-axing-200-california-rd-rest...?#ixzz20obLiLxi
Subscribe: http://www.fiercebiotech.com/signup?sourceform=Viral-Tynt-FierceBiotech-Fierc...
No comments:
Post a Comment